Institutional members access full text with Ovid®

Share this article on:

Association of hypermagnesemia and blood pressure in the critically ill

Celi, Leo A.a,b; Scott, Daniel J.b; Lee, Joonb,c; Nelson, Rachela; Alper, Seth L.a; Mukamal, Kenneth J.a; Mark, Roger G.b; Danziger, Johna

doi: 10.1097/HJH.0b013e3283642f18
ORIGINAL PAPERS: Epidemiology

Background: Although magnesium is important in the biology of blood pressure regulation, little clinical data exist on the association of hypermagnesemia and blood pressure.

Method: We examined the association of hypermagnesemia and SBP in a cross-sectional study of 10 521 ICU patients from a single tertiary care medical center, 6% of whom had a serum magnesium above 2.6 mg/dl at time of admission.

Results: In a multivariable analysis, hypermagnesemia was associated with SBP 6.2 mmHg lower [95% confidence interval (CI) −8.2, −4.2, P < 0.001] than in patients with admission values of serum magnesium 2.6 mg/dl or less. Each mg/dl increase in serum magnesium was associated with a decrease in SBP of 4.3 mmHg (95% CI −5.5, −3.1, P < 0.001). In addition, hypermagnesemic patients had a 2.48-fold greater likelihood (95% CI 2.06, 3.00, P < 0.001) of receiving intravenous vasopressors during the first 24 h of ICU care, independent of admission SBP.

Conclusion: Our findings add support to the biologic importance of magnesium regulation in blood pressure control.

aBeth Israel Deaconess Medical Center, Department of Medicine

bHarvard-MIT Division of Health Sciences and Technology

cSchool of Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada

Correspondence to John Danziger, MD, MPhil, 185 Pilgrim Road, Farr 8, Boston, MA 02215, USA. Tel: +1 617 632 9880; fax: +1 617 632 9890; e-mail: jdanzige@bidmc.harvard.edu

Abbreviations: BUN, blood urea nitrogen; ICU, intensive care unit; ESRD, end stage renal disease; TRPM, transient receptor potential melastatin; WBC, white blood cell count

Received 22 January, 2013

Revised 9 May, 2013

Accepted 12 June, 2013

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins